TY - JOUR
T1 - Kinase inhibitors for advanced medullary thyroid carcinoma
AU - Schlumberger, Martin
AU - Massicotte, Marie Hélène
AU - Nascimento, Camila L.
AU - Chougnet, Cécile
AU - Baudin, Eric
AU - Leboulleux, Sophie
PY - 2012/7/23
Y1 - 2012/7/23
N2 - The recent availability of molecular targeted therapies leads to a reconsideration of the treatment strategy for patients with distant metastases from medullary thyroid carcinoma. In patients with progressive disease, treatment with kinase inhibitors should be offered.
AB - The recent availability of molecular targeted therapies leads to a reconsideration of the treatment strategy for patients with distant metastases from medullary thyroid carcinoma. In patients with progressive disease, treatment with kinase inhibitors should be offered.
KW - Molecular Targeted Therapy
KW - Thyroid Neoplasms
UR - http://www.scopus.com/inward/record.url?scp=84863906261&partnerID=8YFLogxK
U2 - 10.6061/clinics/2012(Sup01)21
DO - 10.6061/clinics/2012(Sup01)21
M3 - Review article
C2 - 22584717
AN - SCOPUS:84863906261
SN - 1807-5932
VL - 67
SP - 125
EP - 129
JO - Clinics
JF - Clinics
IS - SUPPLEMENT
ER -